Treatment Response of Chronic Hepatitis C Patients and Health-Related Quality of Life

Comparative Study between Efficacy of Two Quadruple DAAs Therapy in Treatment of HCV Relapsers

A PREDICTIVE AND COMPARATIVE STUDY VIA VIRAL AND BIOCHEMICAL MEASUREMENTS FOR RESPONDERS AND NON-RESPONDERS EGYPTIAN HEPATITIS C PATIENTS TO DACLATASVIR PLUS SOFOSBUVIR THERAPY

Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Predictors of Sustained Virological Response in Chronic Hepatitis C Patients Treated with Current Direct Acting Antiviral Drugs

Characterization of Drug –resistance Profiles to Directly Acting Agents in Hepatitis C virus Naive Patients

EVALUATION OF DURABILITY OF SUSTAINED VIROLOGICAL RESPONSE (S.V.R.) IN CHRONIC HEPATITIS C TREATED PATIENTS

Comparison between clinical and biochemical versus interleukin 28B as a predictive factor of virological response to direct antiviral drugs without interferone in treatment of hepatitis C virus patients

Response to Hepatitis B Vaccine in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals

Association of STAT-1, IFNAR-2 & IRS-2 Gene Expression in Subjects with Hepatitis C (HCV) Resistant and Responding to Interferon Therapy